Načítá se...
Time to really share real-world data?
Data other than that from clinical trials are important for healthcare decision making. However, unlike the vocal calls seen for more open access to trial data, there are limited efforts being made to ensure that agencies that collect real-world data (RWD) share this, despite its importance. There a...
Uloženo v:
| Vydáno v: | F1000Res |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
F1000 Research Limited
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6192440/ https://ncbi.nlm.nih.gov/pubmed/30364186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.15517.1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|